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THE purpose of this study is to assess the role of
nitric oxide (NO) in the intestinal lesions of pas-
sive anaphylaxis, since this experimental model
resembles necrotizing enterocolitis. Sprague-
Dawley rats were sensitized with IgE anti-dinitro-
phenol monoclonal antibody. Extravasation of
protein-rich plasma and haemorrhagia were mea-
sured in the small intestine. Plasma histamine
was measured to assess mast cell activation. The
effect of exogenous NO on the lesions was
assessed by using two structurally unrelated NO-
donors: sodium nitroprusside and S-nitroso-N-
acetyl-penicillamine (SNAP). An increased basal
production of NO was observed in cells taken
after anaphylaxis, associated with a reduced re-
sponse to platelet-activating factor, interleukin 1b,
and IgE/DNP-bovine serum albumin complexes.
The response to bacterial lipopolysaccharide and
dibutyryl cyclic adenosine monophosphate (AMP)
was enhanced 24 h after challenge, but at earlier
times was not signi￿ cantly different from that
observed in controls. Treatment with either so-
dium nitroprusside or SNAP produced a signi￿ -
cant reduction of the haemorrhagic lesions,
which are a hallmark of rat anaphylaxis. The
extravasation of protein-rich plasma was not in-
￿ uenced by NO-donors. The increase of plasma
histamine elicited by the anaphylactic challenge
was not in￿ uenced by SNAP treatment. NO-donors
protect intestinal haemorrhagic lesions of rat
anaphylaxis by a mechanism apparently indepen-
dent of mast cell histamine release.
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tizing enterocolitis, Platelet-activating factor
Introduction
Necrosis of the small intestine similar to that
produced by endotoxin, tumour necrosis factor1
or platelet-activating factor2 is a feature charac-
teristic of rat anaphylaxis,3,4 its pathogenetic
mechanism being a direct consequence of
triggering the cascade of chemical mediators
from mast cells by IgE-dependent mechanisms.
This necrosis is histologically identical to that
seen in neonatal necrotizing enterocolitis. In a
previous study we have shown that platelet-
activating factor (PAF) is a major effector of this
response. Interestingly, the haemorrhagic le-
sions were dependent on different chemical
mediators than those involved in the production
of protein-rich plasma extravasation.5 Nitric
oxide (NO) plays an important role in cell
signalling (for review see Ref. 6) and it has been
found in a number of cells that are either
directly or indirectly activated in anaphylactic
reactions. In addition, NO mediates in￿amma-
tory responses and defence mechanisms includ-
ing killing of microorganisms, oedema and
apoptosis. The analysis of the actual role of NO
in immunoin￿ammatory reactions is a matter of
debate since it has been reported to produce
either tissue injury7 9 or attenuation of the
damage induced by other agents.10 12
NO affects the function of immune cells by
different mechanisms, e.g. interaction with gua-
nylyl cyclase or interference with the transcrip-
tion factor NF-kB, which among many other
functions is the main regulator of the molecules
that are involved in the production of endothe-
lial cell activation.13,14 The effect of NO as a
mediator of gastrointestinal mucosal defence is
currently associated with its action as an en-
dogenous scavenger of various free radical
species, and there is convincing evidence that
Mediators of In¯ ammation ´ Vol 6 ´ 1997 25administration of large amounts of NO does not
cause detectable damage to the mucosa or
vasculature of the intestine.15
Since there is a host of signals that may lead
to the production of NO, analysis of the
mechanism involved in NO production during
anaphylactic reactions should consider a num-
ber of alternatives. Thus, release of NO by rat
serosal mast cells has been reported.16 Macro-
phages are another source of NOand a number
of autacoids released from mast cells could
potentially lead to the induction of NO produc-
tion by macrophages, e.g. PAF17 and tumour
necrosis factor-alpha (TNF-a).18 Moreover, it has
been recently reported that IgE-dependent acti-
vation of macrophages via FceRII CD23 (low
af￿nity receptor for the Fc portion of IgE) leads
to a strong induction of NO production in both
rat19 and human macrophages20 that allows
killing of parasites. In keeping with these data,
induction of the inducible isoform of NO
synthase during anaphylaxis might occur via
either direct or indirect IgE-dependent mechan-
isms. Even though NO is produced during
anaphylactic challenge, its main role in the
process may be dif￿cult to understand in view
of both its pleiotropic effects and different time-
frames in which it is generated. In this study we
have addressed: (1) the effect of IgE-dependent
anaphylaxis on the generation of NO by rat
peritoneal macrophages; (2) the effect of NO-
generating compounds on the necrotic lesions
of the small intestine produced in IgE-depen-
dent reactions; (3) the effect of NO donors on
histamine release in IgE-dependent anaphylaxis.
Materials and Methods
Materials and drugs
Monoclonal anti-dinitrophenol (DNP) IgE was
obtained from a secreting hybridoma21 grown as
ascites tumours in BALB c mice and puri￿ed by
ammonium sulphate precipitation as described.4
The amount of speci￿c antibody was calculated
from classical precipitation reactions using anti-
gen and several dilutions of the antibody
solution.22 Dinitrophenol-bovine serum albumin
(BSA) containing 8 mol of DNP per mol of BSA
was prepared according to the method of
Eisen.23 IgE-DNP-BSA immune complexes at
equivalence were made by overnight incuba-
tion at 48 C of antigen and the antibody solu-
tion followed by extensive washing.22 1-Hexade-
cyl-2-acetyl-sn-glycero-3-phosphocholine (PAF),
4b-phorbol 12b-myristate 13a-acetate (PMA),
S-nitroso-N-acetyl-penicillamine (SNAP), N-acetyl-
DL-penicillamine, and NG-methyl-arginine (L-
NMA) were from Sigma Chemical Company, St
Louis, MO. Sodium nitroprusside (SNP) was
from Fides Laboratories, Spain. TNF-a and inter-
leukin 1b were from Genzyme Corp., Cam-
bridge, MA.
In vivo experimental design
Male Sprague-Dawley rats of about 200 g body
weight were passively sensitized with IgEmono-
clonal antibody (i.p., in 0.2 ml of a phosphate-
buffered isotonic saline solution, pH7.4) at the
dose of 12 mg protein kg measured by the
method of Bradford.24 Anaphylactic challenge
was performed by i.v. injection with 0.7 mg kg
DNP-BSA together with 20 mg kg Evans blue
dye (EB) in phosphate-buffered isotonic saline
solution to assay protein-rich plasma extravasa-
tion (see below) 18 h after sensitization.25 The
experimental protocol was approved by our
Institutional Review Board.
Assay of NO production by
peritoneal macrophages ex vivo
Peritoneal cells were collected in 50 ml of
Dulbecco’s modi￿ed Eagle medium (DMEM)
without phenol red, pelleted and resuspended
in the same medium supplemented with
100 U ml penicillin, 100 mg ml streptomycin,
50 mg ml gentamicin, 0.5 mML-arginine, 2 mM
glutamine and 10% heat-inactivated fetal calf
serum. Non-adherent cells were removed by
washing after 2 h of incubation, and the produc-
tion of NO was assessed after incubation at
378 C in an atmosphere containing 5% CO2.
More than 95% of the adherent cells were
macrophages as assessed by both their morpho-
logical appearance and functional ability to
engulf non-opsonized zymosan particles. Mast
cells were , 0 5% of total adherent cells as
judged from staining with toluidine blue solu-
tion at pH3.5.
Determination of NO and nitrite
NO released from macrophage cultures was
determined by the accumulation of nitrite.26
The cell cultures (5 3 105 in 1 ml of phenol
red-free medium) were ￿lled with 100 ml of a
solution of 1 mMsulphanilic acid and 100 mM
HCl (￿nal concentration). After incubation for
5 min the medium was aspirated and centri-
fuged in an Eppendorf microcentrifuge. Fifty ml
of naphthylenediamine (1 mM in the assay)
were added to the samples, and the reaction
was completed after 15 min of incubation. The
absorbance at 548 nm was compared with a
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was expressed as nmol of NO2 mg protein.
Evaluation of protein-rich plasma
extravasation
Vascular permeability changes were evaluated
by the EB extravasation method, as described
by Jancar et al.27 The EB was injected into the
jugular vein together with the antigen. The
jejunum-ileum was dissected, weighed, and put
in formamide (4ml g wet tissue at 208 C for
24 h) to extract the EB. The concentration of
EB was determined by spectrophotometry at a
wavelength of 620 nm. The results were plotted
on a standard curve of EB, and the content of
each sample was expressed as mg per gram of
dry weight tissue. Dry weight was obtained by
weighing the tissue after 24 h at 608 C.
Extraction and quantitation of
haemoglobin from intestinal tissue
The concentration of haemoglobin was deter-
mined colorimetrically by the cyanomethaemo-
globin method28 using reagents from Sigma,
according to the modi￿cations carried out by
T avares de Lima et al.29 Brie￿y, fragments of the
ileal-jejunal portions of the small intestine were
excised and minced in 2 ml of potassium
cyanide and hexacyanoferrate solution. After
24 h at room temperature in the dark, the tissue
was removed, the sample was centrifuged and
the optical density of the supernatant was
determined spectrophotometrically at 546 nm.
The concentration of haemoglobin was calcu-
lated by comparison with a standard curve and
was expressed as mg per gram of dry weight
tissue. There is no signi￿cant interference of EB
in this colorimetric assay, making both assays in
samples from the same animal possible.
Assay of histamine released after
antigen challenge
Histamine was measured in plasma by a mod-
i￿cation of the method of Shore et al.30 Brie￿y,
blood was taken from a femoral artery cannu-
lated with a polyethylene catheter, anticoagu-
lated with edetic acid (EDTA), cooled at 48 C
and centrifuged to remove cells. Histamine was
extracted from 200 ml plasma samples by 0.4 N
perchloric acid treatment, followed by sequen-
tial extractions in butanol and heptane. The
￿uorometric assay was carried out after conden-
sation of histamine with o-phthalaldehyde at
alkaline pH. The ￿uorescent product was mea-
sured at room temperature with wavelength
excitation at 360 nm and emission at 450 nm.
The concentration of histamine was determined
from a standard curve constructed with known
concentrations of histamine. For these experi-
ments, the animals were anaesthetized with
pentobarbital sodium (60 mg kg body weight),
and a tracheostomy was then performed to
facilitate breathing.
Statistical analyses
Data are expressed as the mean SEM. For
comparison of two groups of samples normally
distributed, the Student’s two-tailed t-test was
used to analyse differences for signi￿cance. For
comparison of two groups of samples not
normally distributed, the Mann-Whitney U-test
was used. Statistical procedures were performed
using a data base and statistical package (Instat,
GraphPAD Software Inc., San Diego, CA),
P, 0 05 was considered signi￿cant.
Results
Anaphylactic challenge triggers NO
production by peritoneal adherent
cells and modi® es their response to
agonists
Adherent cells collected after induction of
anaphylaxis spontaneously produced increased
amounts of nitrite compared with cells from
animals treated with either antigen or antibody
alone (Fig. 1). This production was suppressed
by the speci￿c NO synthase inhibitor L-NMA,
but not by D-NMA suggesting the involvement
of the L-arginine pathway in the production of
NO under these conditions. The time elapsed
after anaphylaxis in￿uenced the ability of adher-
ent peritoneal cells to produce NO, since
maximal production was observed in cells
collected 24 h after anaphylaxis (Fig. 1). Further
approaches to analyse the mechanism of the
enhanced production of NO was carried out by
examining the response of adherent peritoneal
cells to a set of agonists that are either released
after anaphylactic challenge or act through well-
known signalling pathways. As shown in Fig. 2,
the pattern of response to these agonists
presented signi￿cant differences that can be
summarized as follows. PMA was the only
agonist that elicited an enhanced nitrite produc-
tion in cells collected 10 min after anaphylaxis
compared with controls. The response to IL-1b,
IgE DNP complexes and PAF was reduced com-
pared with controls, except in cells taken 24 h
after challenge. LPS and dibutyryl cyclic adeno-
sine monophosphate (AMP) elicited on cells
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NO in rat anaphylaxisfrom DNP-challenged animals a response similar
to that observed in control rats, except when
the cells were collected 24 hours after anaphy-
laxis, on which they elicited an increased
production of nitrate. TNF-a at concentrations
up to 1 nM did not induce signi￿cant NO
production.
Treatment with SNP and SNAP prior
to the anaphylactic reaction
decreases haemorrhagic necrosis of
the small intestine
Attempts to delineate the effect of NO on rat
anaphylaxis were performed with SNP and
SNAP , two NO-generating compounds that are
not structurally related. Treatment with SNP at
the dose of 0.1 mg kg, i.p., prior to anaphylac-
tic challenge, induced a signi￿cant reduction of
the haemorrhagic necrosis without affecting
extravasation signi￿cantly as judged from the
accumulation of EB (Fig. 3). A similar effect was
observed with SNAP at the dose of 1 mg kg i.p.
prior to the challenge with DNP-BSA. A group
of rats treated with 1.4 mg kg of N-acetyl-
penicillamine showed no protection at all,
which indicates that the effect of SNAP should
be attributed to its nitrosyl moiety. Inhibition of
NO synthesis with L-NMA at the dose of
10 mg kg did not elicit signi￿cant changes on
the haemorrhagic necrosis, suggesting that the
amount of NO that can be produced early after
anaphylactic challenge from the constitutive
isoform of NO synthase does not attain a






































































































FIG. 1. Spontaneous production of nitrite by adherent peri-
toneal cells in culture after anaphylactic challenge. Perito-
neal cells were collected at the times indicated after
anaphylactic challenge by washing the peritoneum with
50 ml of DMEM, followed by centrifugation and resuspen-
sion in 10 ml of the same medium. Cells non-adherent to
plastic dishes were removed after 2 h and the production of
nitrate nitrite assayed 24 h thereafter with the Griess
reagents. Control animals included rats treated with either
antibody or antigen alone and collected 24 h thereafter. The
cross-hatched columns show the accumulation of nitrite in
the presence of either the NO synthase inhibitor L-NMA or
its isomer D-NMA. Data represent mean SEM of 12 to 15







































































































FIG. 2. Production of nitrite by adherent peritoneal cells
from rats undergoing anaphylactic challenge stimulated
with different agonists. Cells were taken after anaphylaxis
as explained in the legend to Fig. 1. Adherent cells were
incubated as indicated with 32 nM PMA, 1 nM IL-1b, 20 nM
PAF, 100mg ml IgE DNP-BSA equivalence preformed inso-
luble immune complexes, 10 mg ml LPS and 0.5 mM
dibutyryl cyclic AMP. The production of nitrite was assayed
24 h after addition of stimuli. Data represent mean SEM
from 12 to 15 animals. P , 0 05 compared with cells from
control animals sensitized with i.p. antibody and challenged
with vehicle.
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the levels of plasma histamine after
anaphylactic challenge
In order to obtain some information about the
level at which the protective effect of SNAP on
the anaphylactic reaction was exerted, hista-
mine plasma levels were assayed at different
times after DNP-BSA challenge as an indicator of
mast cell activation and degranulation. Injection
of DNP-BSA to sensitized rats produced a rapid
increase of plasma histamine levels from
0 028 0 007 mM to 0 8 0 24 mM 5 min after
challenge. This was followed by a decline of
plasma histamine after 10 min. Assay of hista-
mine plasma levels in rats pretreated with SNAP
at both the usual dose of 1 mg kg (Fig. 4) and
at 4 mg kg (not shown) did not induce any
signi￿cant decrease of plasma histamine levels.
Discussion
In previous studies we have observed that
triggering of anaphylactic reactions in rats
passively sensitized with monoclonal antibody
produces shock, extravasation of protein rich
plasma, and severe lesions of the small intestine
characterized by coagulative necrosis of the
epithelial layer, oedema in the lamina propria,
and extravasation of blood red cells into the
interstitium.4,5 These changes are due to the
triggering of the cascade of chemical mediators
released from mast cells, and are analogous to
those produced by the infusion of PAF .2,31 In the
present study we show that triggering of the
anaphylactic reaction also induces NO produc-
tion by adherent peritoneal cells and modi￿es
the response of these cells to NO-inducers. This
seems to be due to the sudden release of a
variety of autacoids that initiate chemical signal-
ling. Analysis of the different molecules that
could be implicated in this signalling should
include products derived from mast cells as well
as direct activation of macrophages by IgE-
antigen complexes via the low af￿nity FceRII
CD23 receptor. Activation of NO production
through this receptor seems to be of potential
importance since it is involved in parasite
killings.20 Among the list of mast-cell derived
products that could induce NO production on
macrophages we focused on PAF , IL-1b, and
TNF-a, based on their well-documented ability
to induce NO production.18,32,33 On the other
hand, to address the chance of a direct trigger-
ing of macrophages via CD23 antigen we have
utilized preformed IgE-DNP complexes. In addi-
tion, we selected other agonists in view of their
unique properties of inducing NO synthase by
well-known biochemical pathways. Thus, LPS
was used as a good reference compound that is
currently used to induce NO production. Dibu-
tyryl cyclic AMP was selected in view of its
well-known effect on mesangial cells, macro-
phages and smooth muscle vascular cells by a
mechanism different from that involved in NO
induction by IL-1b.34 PMA was used as an
Control L-NMA SNP Penicillamine SNAP




































































































FIG. 3. Effect of NO-generating compounds on the accumu-
lation of both Evans blue dye and haemoglobin in the small
intestine of IgE-sensitized rats undergoing anaphylactic
challenge. Drugs were administered 10 min prior to antigen
challenge at the doses indicated. Rats were sacri® ced
15 min after anaphylaxis to obtain small intestine samples.
The line at the base of the columns shows mean control
values obtained in 10 IgE-sensitized rats challenged with
vehicle. Open columns indicate haemoglobin accumulation.
Hatched bars indicate Evans blue dye accumulation. Data
represent mean SEM from 14 to 16 rats. P , 0 05.
Time (min)



























FIG. 4. Plasma histamine concentration after anaphylactic
challenge. The femoral artery of rats was cannulated with
polyethylene catheter and 0.4 ml blood samples were taken
before (arrow) and at different times after DNP-BSA admin-
istration. Open circles indicate rats treated with vehicle.
Closed circles indicate rats pretreated with 1 mg kg SNAP.
Data represent mean SEM of 15± 18 animals at each
point. Differences were not signi® cant at any of the times
tested.
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NO in rat anaphylaxisinductor of NO production by protein kinase C-
dependent mechanisms.35 Analysis of the re-
sponses to these agonists after anaphylaxis
showed down-regulation of the responses to
some of them, namely IL-1b, PAF and IgE DNP
complexes, suggesting that cells could have
reacted with these stimuli prior to ex vivo
stimulation, this event leading to a cross-talk of
signals. This is in keeping with what could be
expected on the basis of the autacoids that are
released after IgE challenge, and could explain
the up-regulation of NOproduction observed in
cells removed after anaphylaxis. In keeping
with this interpretation, an increased concentra-
tion of NOhas been detected in the exhaled air
of patients after allergen-induced late asthmatic
reactions,36 and this has been considered a good
indicator of the degree of in￿ammation of the
airways. This also agrees with the enhanced
production of NOby peritoneal cells taken after
the induction of immune-complex peritonitis.17
To de￿ne the pathophysiological conse-
quences of the modulation of NO production
during anaphylaxis we ￿rst carried out experi-
ments with L-NMA to inhibit NO production.
This treatment did not modify the extent of
both haemorrhagia and extravasation in animals
undergoing anaphylactic challenge. This is dif-
ferent from the reported increase of epithelial
permeability produced by inhibition of NO
synthase via activation of mucosal mast cells,
which has been associated with the release of
PAF , histamine and superoxide.37 A likely expla-
nation could be the time-frame in which these
changes occur, since in that report they were
maximal 30 min after treatment with the NO
synthase inhibitor. Another reason could be that
NO synthase inhibition on its own initiates the
generation of mediators by mast cells and,
thereby, enhances the release of chemical med-
iators triggered by anaphylaxis. Since the magni-
tude of tissue injury is very prominent in our
model, it seems dif￿cult to enhance damage by
pharmacological procedures.
On the other hand, treatment with two
structurally unrelated NO-generating com-
pounds showed a signi￿cant protection of the
haemorrhagic component of the lesions without
reducing protein-rich plasma extravasation. It is
not fully unexpected that haemorrhagia and
exudation show different pharmacological mod-
ulation. A likely explanation for this ￿nding is
that the occurrence of haemorrhagia might
require a wide disruption of the integrity of
endothelial cells, compared with the mild
changes needed for protein-rich plasma extra-
vasation to occur. This agrees with the results
we observed antagonizing the PAFreceptor.5
Since a portion of the effect of NO on
gastrointestinal mucosal defence has been asso-
ciated to its role as an endogenous modulator of
mast cell reactivity,16,38 we measured plasma
histamine after anaphylactic challenge as a
reporter of mast cell activation. Plasma hista-
mine concentrations in SNAP-treated animals
were not signi￿cantly different from those
measured in non-treated animals after antigen
challenge, making it unlikely that the alleviation
of intestinal haemorrhagia produced by NO-
generating compounds could only be explained
by an overall inhibition of mast cell activation.39
In fact, the assay of plasma histamine is only an
indicator of mast cell activation, whereas other
mediators, e.g. PAF , seem to be the actual
effectors of the injury.5 However, the recent
report of the blockade of PAF-induced bowel
injury by NO-donors40 strongly suggests that
these compounds operate downstream the mast
cell activation step.
Potential targets of NO are redox-sensitive
signalling pathways which include protein tyr-
osine phosphatases and kinases that are affected
by covalent interactions with sulphydryl
groups.41,42 This seems of interest because
protein tyrosine phosphorylation reactions are
involved in biochemical signalling in the micro-
circulation.43 NO also has effects on the tran-
scription factor NF-kB. This action is linked to
the ability of NO to scavenge and inactivate
superoxide anion,44 and might be of central
importance in vascular biology because NF-kBis
involved in endothelial cell activation by pro-
moting the expression of adhesion molecules
and proin￿ammatory cytokines.13,14 Transcrip-
tional activation of the p50 subunit of NF-kB
has been demonstrated in the small bowel of
mice treated with either PAF or TNF-a at
concentrations lower than those required to
produce systemic changes.45 Therefore, the
effect of NO-generating compounds in the
attenuation of the haemorrhagic necrosis asso-
ciated with IgE-dependent mast cell activation
should be related to these types of interactions
rather than to the inhibition of the release of
mediators from mast cells.
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